Merck Names China Expert as Directory of Strategy
publication date: Sep 28, 2011
Merck, known as MSD outside the United States and Canada, selected a member of WuXi PharmaTech’s board of directors to be its own Chief Strategy Director. Cuong Viet Do has experience in both healthcare and M&A, in addition to familiarity with China business. From 1989 to 2006, Do was a director and senior partner at McKinsey & Company, where he worked in global healthcare and then high-tech/corporate finance in China and Asia. Because of his extensive experience in Asia, Do’s appointment underscores the significance of China and Asia to Merck. More details....
Stock Symbols: (NYSE: MRK) (NYSE: WX)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.